Mahesh J Shetty, MD
Sleep Medicine · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Offices
- 2
Offices
2 locations · Physician Services at El Camino Hospital · 10 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shetty’s office at (917) 562-5960 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A129323 · Current
Licensed to practise in California · since 2014 · expires 2027-04-30 · University of Mumbai, Lokmanya Tilak Municipal Medical College.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$153,104
Medicare paid this office $153,104 for 339 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 96 | $48,028 | $187 |
| Return visit (30+ min) | 172 | $32,430 | $114 |
| Critical care, each additional 30 minutes | 67 | $22,257 | $94 |
| Sleep study in sleep lab (6 years or older) | 21 | $14,260 | $679 |
| Long return visit (40+ min) | 53 | $13,256 | $164 |
See all 13 services
| Critical care, first 30-74 minutes | 96 | $48,028 | $187 |
| Return visit (30+ min) | 172 | $32,430 | $114 |
| Critical care, each additional 30 minutes | 67 | $22,257 | $94 |
| Sleep study in sleep lab (6 years or older) | 21 | $14,260 | $679 |
| Long return visit (40+ min) | 53 | $13,256 | $164 |
| New patient visit (60+ min) | 36 | $6,208 | $172 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 24 | $1,176 | $41 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $1,070 | $97 |
| Insertion of artery tube for blood sampling or infusion through skin | 14 | $529 | $38 |
| Test to determine lung volumes using sensors | 33 | $358 | $11 |
| Test for exercise-induced lung stress | 17 | $332 | $20 |
| Test to examine how well the lungs exchange gases | 33 | $265 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $154 | $9 |
Who their Medicare patients are
339 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 20% · Women 44% · Also on Medicaid 20% · Health risk score 1.97. Sicker patients than 9 in 10 peers; the typical sleep medicine clinician is at 1.21.
Conditions among them: High blood pressure 75% · Diabetes 39% · COPD 39% · Coronary heart disease 38% · Heart failure 35% · Atrial fibrillation 34% · Chronic kidney disease 30% · Depression 29% · Cancer 22% · Stroke 21% · Dementia 17%.
The office billed $652,926, Medicare allowed $197,661 and paid $153,104; for 1,158 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 339 | 1,158 | 77 | 1.97 | $652,926 | $153,104 |
| 2023 | 476 | 1,841 | 77 | 1.95 | $1,048,298 | $245,527 |
| 2022 | 527 | 2,033 | 76 | 2.07 | $1,191,128 | $276,929 |
| 2021 | 552 | 1,882 | 77 | 1.96 | $1,202,332 | $280,529 |
| 2020 | 502 | 1,595 | 76 | 2.25 | $978,241 | $220,691 |
| 2019 | 604 | 2,174 | 76 | 2.10 | $1,164,978 | $282,131 |
| 2018 | 491 | 1,979 | 77 | 2.22 | $931,197 | $243,681 |
| 2017 | 523 | 2,189 | 77 | 2.02 | $728,898 | $266,367 |
| 2016 | 488 | 2,187 | 78 | 2.36 | $448,980 | $209,893 |
| 2015 | 384 | 1,884 | 80 | 2.23 | $351,644 | $174,481 |
| 2014 | 204 | 644 | 78 | 2.18 | $140,219 | $66,917 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Critical care, first 30-74 minutes | 179 | $84,854 | $189 |
| Return visit (30+ min) | 202 | $44,612 | $115 |
| Critical care, each additional 30 minutes | 112 | $32,375 | $96 |
| Long return visit (40+ min) | 75 | $17,911 | $159 |
| Sleep study in sleep lab (6 years or older) | 27 | $17,353 | $643 |
| New patient visit (60+ min) | 60 | $12,094 | $202 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 15 | $11,124 | $695 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $5,819 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,058 | $109 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,500 | $114 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 30 | $1,622 | $41 |
| Insertion of artery tube for blood sampling or infusion through skin | 16 | $700 | $39 |
| Test to determine lung volumes using sensors | 53 | $567 | $10 |
| Test for exercise-induced lung stress | 24 | $496 | $19 |
| Test to examine how well the lungs exchange gases | 52 | $411 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 30 | $275 | $9 |
2022: 19 services
| Critical care, first 30-74 minutes | 197 | $98,633 | $193 |
| Return visit (30+ min) | 193 | $37,060 | $111 |
| Long return visit (40+ min) | 116 | $34,737 | $165 |
| Critical care, each additional 30 minutes | 106 | $31,245 | $98 |
| Sleep study in sleep lab (6 years or older) | 26 | $17,653 | $654 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 20 | $13,749 | $687 |
| New patient visit (60+ min) | 68 | $13,116 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $7,443 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $4,599 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,312 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,147 | $179 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 29 | $1,628 | $41 |
| Short return visit (20+ min) | 15 | $1,584 | $83 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $1,043 | $75 |
| Insertion of artery tube for blood sampling or infusion through skin | 21 | $856 | $39 |
| Test for exercise-induced lung stress | 33 | $689 | $20 |
| Test to determine lung volumes using sensors | 54 | $556 | $10 |
| Test to examine how well the lungs exchange gases | 56 | $412 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 28 | $215 | $8 |
2021: 18 services
| Critical care, first 30-74 minutes | 230 | $99,172 | $199 |
| Return visit (30+ min) | 184 | $37,714 | $117 |
| Long return visit (40+ min) | 129 | $37,260 | $157 |
| Sleep study in sleep lab (6 years or older) | 33 | $23,068 | $678 |
| New patient visit (60+ min) | 87 | $17,670 | $203 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 22 | $16,297 | $709 |
| Critical care, each additional 30 minutes | 66 | $16,058 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $7,082 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $5,257 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $3,014 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,875 | $169 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,086 | $84 |
| Test for exercise-induced lung stress | 27 | $896 | $32 |
| Insertion of artery tube for blood sampling or infusion through skin | 13 | $558 | $40 |
| Test to determine lung volumes using sensors | 50 | $513 | $10 |
| Test to examine how well the lungs exchange gases | 51 | $388 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 36 | $306 | $8 |
| Test for exercise-induced lung stress | 13 | $269 | $21 |
2020: 16 services
| Critical care, first 30-74 minutes | 221 | $104,781 | $202 |
| Long return visit (40+ min) | 155 | $36,984 | $133 |
| Critical care, each additional 30 minutes | 61 | $14,956 | $102 |
| Return visit (30+ min) | 117 | $14,481 | $87 |
| Sleep study in sleep lab (6 years or older) | 14 | $9,070 | $648 |
| New patient visit (60+ min) | 50 | $8,431 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $7,958 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,995 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,554 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,259 | $188 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $1,081 | $77 |
| Test for exercise-induced lung stress | 20 | $722 | $33 |
| Insertion of artery tube for blood sampling or infusion through skin | 13 | $565 | $40 |
| Test to determine lung volumes using sensors | 27 | $308 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 23 | $278 | $12 |
| Test to examine how well the lungs exchange gases | 26 | $219 | $8 |
2019: 17 services
| Critical care, first 30-74 minutes | 219 | $79,583 | $195 |
| Long return visit (40+ min) | 236 | $70,354 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $23,084 | $65 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 31 | $22,789 | $670 |
| Sleep study in sleep lab (6 years or older) | 32 | $20,876 | $614 |
| New patient visit (60+ min) | 80 | $14,302 | $179 |
| Return visit (30+ min) | 102 | $13,351 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 59 | $9,001 | $120 |
| Critical care, each additional 30 minutes | 45 | $6,263 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,742 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,258 | $181 |
| Test for exercise-induced lung stress | 50 | $1,869 | $32 |
| Influenza vaccine split virus, preservative free | 33 | $1,806 | $55 |
| Administration of influenza virus vaccine | 37 | $759 | $21 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 48 | $556 | $12 |
| Test to determine lung volumes using sensors | 45 | $489 | $11 |
| Test to examine how well the lungs exchange gases | 44 | $353 | $8 |
2018: 19 services
| Critical care, first 30-74 minutes | 145 | $63,012 | $196 |
| Long return visit (40+ min) | 199 | $53,200 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $25,952 | $65 |
| Return visit (30+ min) | 126 | $19,607 | $99 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 24 | $17,847 | $686 |
| Sleep study in sleep lab (6 years or older) | 21 | $13,723 | $653 |
| Critical care, each additional 30 minutes | 60 | $13,047 | $98 |
| New patient visit (60+ min) | 61 | $11,071 | $181 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 72 | $9,425 | $121 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,729 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,685 | $94 |
| Test for exercise-induced lung stress | 30 | $1,205 | $33 |
| Influenza vaccine split virus, preservative free | 23 | $1,203 | $52 |
| Administration of influenza virus vaccine | 25 | $643 | $26 |
| Insertion of artery tube for blood sampling or infusion through skin | 14 | $542 | $39 |
| Test to determine lung volumes using sensors | 37 | $433 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 29 | $359 | $12 |
| Test to examine how well the lungs exchange gases | 38 | $320 | $8 |
| Test for exercise-induced lung stress | 11 | $227 | $21 |
2017: 18 services
| Return visit (30+ min) | 241 | $52,401 | $91 |
| Critical care, first 30-74 minutes | 114 | $49,201 | $190 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 52 | $39,068 | $601 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $28,321 | $63 |
| Sleep study in sleep lab (6 years or older) | 35 | $23,425 | $601 |
| New patient visit (45+ min) | 126 | $15,929 | $126 |
| Long return visit (40+ min) | 88 | $13,401 | $134 |
| Critical care, each additional 30 minutes | 62 | $13,297 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 69 | $9,234 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,392 | $176 |
| New patient visit (60+ min) | 16 | $2,757 | $172 |
| Influenza vaccine split virus, preservative free | 24 | $1,237 | $48 |
| Administration of influenza virus vaccine | 27 | $912 | $30 |
| Short return visit (20+ min) | 14 | $864 | $58 |
| Test to determine lung volumes using sensors | 46 | $511 | $11 |
| Pulmonary exercise testing | 17 | $468 | $28 |
| Test to examine how well the lungs exchange gases | 46 | $377 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 23 | $271 | $11 |
2016: 17 services
| Critical care, first 30-74 minutes | 131 | $53,695 | $192 |
| Return visit (30+ min) | 192 | $47,478 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 127 | $40,484 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 123 | $18,931 | $118 |
| New patient visit (45+ min) | 96 | $13,952 | $145 |
| Critical care, each additional 30 minutes | 52 | $11,640 | $96 |
| Short return visit (20+ min) | 55 | $4,964 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,003 | $177 |
| New patient visit (30+ min) | 13 | $1,074 | $83 |
| Influenza vaccine split virus, preservative free | 22 | $858 | $39 |
| Pneumococcal vaccine, 23-valent | 11 | $809 | $74 |
| Administration of influenza virus vaccine | 28 | $561 | $20 |
| Insertion of artery tube for blood sampling or infusion through skin | 12 | $525 | $44 |
| Administration of pneumococcal vaccine | 15 | $475 | $32 |
| Test to determine lung volumes using sensors | 36 | $399 | $11 |
| Test to examine how well the lungs exchange gases | 37 | $303 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $224 | $12 |
2015: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 134 | $45,203 | $64 |
| Return visit (30+ min) | 150 | $37,393 | $97 |
| Critical care, first 30-74 minutes | 92 | $34,744 | $196 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 106 | $15,774 | $120 |
| New patient visit (45+ min) | 65 | $9,852 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,865 | $181 |
| Pneumococcal vaccine, 13-valent | 37 | $6,109 | $165 |
| Short return visit (20+ min) | 62 | $5,556 | $67 |
| Critical care, each additional 30 minutes | 12 | $2,065 | $98 |
| Administration of pneumococcal vaccine | 40 | $1,268 | $32 |
| Influenza vaccine split virus, preservative free | 26 | $925 | $36 |
| Administration of influenza virus vaccine | 27 | $549 | $20 |
| Test to determine lung volumes using sensors | 28 | $311 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 21 | $248 | $12 |
| Test to examine how well the lungs exchange gases | 26 | $213 | $8 |
2014: 9 services
| Critical care, first 30-74 minutes | 45 | $16,707 | $192 |
| New patient visit (45+ min) | 98 | $14,875 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $12,125 | $64 |
| Return visit (30+ min) | 49 | $8,807 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,286 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,264 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,799 | $122 |
| Administration of influenza virus vaccine | 26 | $510 | $20 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 26 | $307 | $12 |
Medicaid work
$1,464 in 2023
Medicaid paid $1,464 for 42 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 42 | $1,464 |
| 2023 | 42 | 1 | 15 | $1,464 |
| 2022 | 55 | 1 | 18 | $967 |
| 2021 | 230 | 1 | 29 | $11,674 |
| 2020 | 288 | 1 | 27 | $12,299 |
| 2019 | 27 | 1 | 12 | $86 |
| 2018 | 22 | 1 | 13 | $1,423 |
See the largest Medicaid services in earlier years
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 55 | $967 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 230 | $11,674 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 288 | $12,299 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 27 | $86 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 22 | $1,423 |
Drugs they prescribed that Part D paid
$172,811
Pharmacies billed $172,811 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
285 generic and 290 brand-name prescriptions · $172,811 in drug cost · 22 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 78 | $63,700 | $817 |
| Spiriva Respimat | 40 | $28,101 | $703 |
| Breo Ellipta | 31 | $18,778 | $606 |
| Breztri Aerosphere | 16 | $10,020 | $626 |
| Symbicort | 16 | $6,917 | $432 |
See all 17 drugs
| Trelegy Ellipta | 78 | $63,700 | $817 |
| Spiriva Respimat | 40 | $28,101 | $703 |
| Breo Ellipta | 31 | $18,778 | $606 |
| Breztri Aerosphere | 16 | $10,020 | $626 |
| Symbicort | 16 | $6,917 | $432 |
| Arnuity Ellipta | 15 | $4,803 | $320 |
| Wixela Inhub | 18 | $3,754 | $209 |
| Albuterol Sulfate Hfa | 32 | $1,038 | $32 |
| Fluticasone Propionate | 34 | $562 | $17 |
| Montelukast | 28 | $543 | $19 |
| Eszopiclone | 18 | $435 | $24 |
| Pramipexole Dihydrochloride | 12 | $341 | $28 |
| Prednisone | 26 | $267 | $10 |
| Zolpidem | 11 | $152 | $14 |
| Trazodone | 19 | $112 | $6 |
| Pantoprazole | 13 | $69 | $5 |
| Azithromycin | 11 | $65 | $6 |
Year by year
| 2024 | 575 | 127 | None | 50% | $172,811 |
| 2023 | 655 | 148 | 0% (0) | 58% | $231,856 |
| 2022 | 737 | 148 | 0% (0) | 59% | $234,401 |
| 2021 | 629 | 115 | None | 57% | $175,560 |
| 2020 | 687 | 106 | 0% (0) | 60% | $181,521 |
| 2019 | 786 | 129 | 0% (0) | 58% | $195,987 |
| 2018 | 643 | 114 | 0% (0) | 59% | $168,349 |
| 2017 | 686 | 130 | 0% (0) | 63% | $180,149 |
| 2016 | 781 | 124 | None | 64% | $192,500 |
| 2015 | 587 | 110 | 0% (0) | 69% | $151,984 |
| 2014 | 117 | 50 | 0% (0) | 62% | $20,290 |
| 2013 | 59 | 18 | 0% (0) | 83% | $59,510 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Trelegy Ellipta | 70 | $64,111 | $916 |
| Breo Ellipta | 58 | $34,368 | $593 |
| Breztri Aerosphere | 33 | $25,377 | $769 |
| Spiriva Respimat | 33 | $21,716 | $658 |
| Advair Diskus | 21 | $14,328 | $682 |
| Symbicort | 25 | $13,903 | $556 |
| Incruse Ellipta | 33 | $12,384 | $375 |
| Anoro Ellipta | 12 | $6,210 | $518 |
| Fluticasone-Salmeterol | 11 | $3,605 | $328 |
| Albuterol Sulfate Hfa | 26 | $1,314 | $51 |
| Ventolin Hfa | 14 | $926 | $66 |
| Eszopiclone | 11 | $757 | $69 |
| Montelukast | 27 | $631 | $23 |
| Fluticasone Propionate | 29 | $439 | $15 |
| Prednisone | 43 | $438 | $10 |
| Pantoprazole | 22 | $284 | $13 |
| Amoxicillin-Clavulanate Potass | 11 | $192 | $17 |
| Zolpidem | 11 | $131 | $12 |
| Trazodone | 22 | $100 | $5 |
| Azithromycin | 11 | $78 | $7 |
2022: 19 drugs
| Trelegy Ellipta | 75 | $53,738 | $717 |
| Breztri Aerosphere | 38 | $28,076 | $739 |
| Breo Ellipta | 59 | $27,981 | $474 |
| Advair Diskus | 32 | $21,970 | $687 |
| Spiriva Respimat | 36 | $19,769 | $549 |
| Symbicort | 26 | $16,720 | $643 |
| Incruse Ellipta | 39 | $15,693 | $402 |
| Anoro Ellipta | 22 | $13,127 | $597 |
| Fluticasone-Salmeterol | 11 | $2,756 | $251 |
| Albuterol Sulfate Hfa | 37 | $2,268 | $61 |
| Wixela Inhub | 14 | $2,113 | $151 |
| Montelukast | 38 | $1,137 | $30 |
| Ventolin Hfa | 14 | $902 | $64 |
| Fluticasone Propionate | 32 | $571 | $18 |
| Azithromycin | 19 | $247 | $13 |
| Prednisone | 33 | $192 | $6 |
| Trazodone | 31 | $132 | $4 |
| Pantoprazole | 13 | $127 | $10 |
| Zolpidem | 19 | $85 | $4 |
2021: 20 drugs
| Spiriva Respimat | 35 | $24,388 | $697 |
| Anoro Ellipta | 38 | $22,582 | $594 |
| Trelegy Ellipta | 32 | $20,971 | $655 |
| Breo Ellipta | 50 | $19,905 | $398 |
| Symbicort | 37 | $19,707 | $533 |
| Advair Diskus | 40 | $19,594 | $490 |
| Incruse Ellipta | 22 | $8,145 | $370 |
| Wixela Inhub | 21 | $6,330 | $301 |
| Spiriva | 12 | $6,138 | $512 |
| Fluticasone-Salmeterol | 13 | $4,259 | $328 |
| Arnuity Ellipta | 16 | $3,680 | $230 |
| Albuterol Sulfate Hfa | 32 | $1,926 | $60 |
| Montelukast | 39 | $910 | $23 |
| Ventolin Hfa | 11 | $710 | $65 |
| Fluticasone Propionate | 17 | $295 | $17 |
| Zolpidem | 26 | $252 | $10 |
| Ropinirole | 22 | $224 | $10 |
| Prednisone | 25 | $157 | $6 |
| Trazodone | 13 | $110 | $8 |
| Clonazepam | 11 | $14 | $1 |
2020: 20 drugs
| Anoro Ellipta | 43 | $25,982 | $604 |
| Spiriva Respimat | 44 | $23,521 | $535 |
| Symbicort | 47 | $22,777 | $485 |
| Breo Ellipta | 48 | $19,152 | $399 |
| Advair Diskus | 32 | $16,689 | $522 |
| Incruse Ellipta | 26 | $9,867 | $380 |
| Trelegy Ellipta | 17 | $9,702 | $571 |
| Spiriva | 20 | $8,574 | $429 |
| Wixela Inhub | 25 | $8,217 | $329 |
| Chantix | 13 | $7,051 | $542 |
| Arnuity Ellipta | 17 | $3,707 | $218 |
| Albuterol Sulfate Hfa | 30 | $2,118 | $71 |
| Fluticasone-Salmeterol | 11 | $2,064 | $188 |
| Fluticasone Propionate | 32 | $583 | $18 |
| Montelukast | 32 | $464 | $14 |
| Prednisone | 53 | $423 | $8 |
| Pantoprazole | 18 | $221 | $12 |
| Zolpidem | 25 | $126 | $5 |
| Sulfamethoxazole-Trimethoprim | 14 | $42 | $3 |
| Clonazepam | 12 | $20 | $2 |
2019: 19 drugs
| Anoro Ellipta | 63 | $32,227 | $512 |
| Spiriva Respimat | 47 | $26,983 | $574 |
| Symbicort | 55 | $21,606 | $393 |
| Advair Diskus | 31 | $17,831 | $575 |
| Incruse Ellipta | 45 | $16,999 | $378 |
| Breo Ellipta | 40 | $15,819 | $395 |
| Spiriva | 18 | $9,493 | $527 |
| Wixela Inhub | 20 | $6,505 | $325 |
| Flovent Hfa | 15 | $5,675 | $378 |
| Ventolin Hfa | 40 | $2,615 | $65 |
| Fluticasone Propionate | 45 | $683 | $15 |
| Prednisone | 75 | $647 | $9 |
| Albuterol Sulfate Hfa | 12 | $642 | $54 |
| Montelukast | 29 | $308 | $11 |
| Pantoprazole | 11 | $193 | $18 |
| Amoxicillin-Clavulanate Potass | 17 | $162 | $10 |
| Zolpidem | 25 | $129 | $5 |
| Azithromycin | 13 | $114 | $9 |
| Furosemide | 12 | $60 | $5 |
2018: 18 drugs
| Advair Diskus | 63 | $45,447 | $721 |
| Spiriva | 38 | $20,818 | $548 |
| Anoro Ellipta | 42 | $19,398 | $462 |
| Spiriva Respimat | 34 | $18,106 | $533 |
| Symbicort | 37 | $14,402 | $389 |
| Incruse Ellipta | 33 | $11,927 | $361 |
| Breo Ellipta | 24 | $8,233 | $343 |
| Flovent Hfa | 17 | $6,470 | $381 |
| Nexium | 11 | $2,967 | $270 |
| Ventolin Hfa | 38 | $2,201 | $58 |
| Fluticasone Propionate | 56 | $717 | $13 |
| Montelukast | 48 | $385 | $8 |
| Prednisone | 42 | $268 | $6 |
| Pantoprazole | 11 | $220 | $20 |
| Levofloxacin | 14 | $216 | $15 |
| Furosemide | 15 | $105 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $96 | $9 |
| Zolpidem | 15 | $19 | $1 |
2017: 19 drugs
| Advair Diskus | 99 | $58,817 | $594 |
| Spiriva | 40 | $27,345 | $684 |
| Breo Ellipta | 47 | $17,265 | $367 |
| Spiriva Respimat | 39 | $15,047 | $386 |
| Symbicort | 33 | $13,040 | $395 |
| Incruse Ellipta | 22 | $8,545 | $388 |
| Anoro Ellipta | 19 | $7,364 | $388 |
| Flovent Hfa | 23 | $6,534 | $284 |
| Nexium | 12 | $2,993 | $249 |
| Proair Hfa | 17 | $1,617 | $95 |
| Ventolin Hfa | 15 | $798 | $53 |
| Prednisone | 56 | $623 | $11 |
| Montelukast | 38 | $480 | $13 |
| Fluticasone Propionate | 26 | $333 | $13 |
| Omeprazole | 18 | $224 | $12 |
| Amoxicillin-Clavulanate Potass | 15 | $139 | $9 |
| Alendronate | 15 | $99 | $7 |
| Zolpidem | 11 | $98 | $9 |
| Furosemide | 21 | $89 | $4 |
2016: 20 drugs
| Advair Diskus | 134 | $60,289 | $450 |
| Spiriva | 71 | $37,254 | $525 |
| Symbicort | 46 | $18,316 | $398 |
| Spiriva Respimat | 46 | $17,014 | $370 |
| Combivent Respimat | 33 | $10,964 | $332 |
| Breo Ellipta | 20 | $7,215 | $361 |
| Anoro Ellipta | 20 | $6,405 | $320 |
| Incruse Ellipta | 20 | $5,507 | $275 |
| Flovent Hfa | 20 | $5,430 | $272 |
| Nexium | 11 | $2,767 | $252 |
| Proair Hfa | 18 | $1,290 | $72 |
| Prednisone | 70 | $899 | $13 |
| Montelukast | 44 | $495 | $11 |
| Levofloxacin | 21 | $403 | $19 |
| Amoxicillin-Clavulanate Potass | 27 | $339 | $13 |
| Fluticasone Propionate | 22 | $265 | $12 |
| Alendronate | 21 | $176 | $8 |
| Omeprazole | 15 | $116 | $8 |
| Azithromycin | 12 | $94 | $8 |
| Furosemide | 12 | $44 | $4 |
2015: 14 drugs
| Advair Diskus | 122 | $51,670 | $424 |
| Spiriva | 121 | $48,987 | $405 |
| Symbicort | 26 | $9,585 | $369 |
| Spiriva Respimat | 14 | $7,159 | $511 |
| Flovent Hfa | 23 | $5,973 | $260 |
| Daliresp | 12 | $3,081 | $257 |
| Proair Hfa | 19 | $1,092 | $57 |
| Montelukast | 29 | $456 | $16 |
| Prednisone | 39 | $437 | $11 |
| Levofloxacin | 16 | $206 | $13 |
| Omeprazole | 19 | $167 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $162 | $15 |
| Fluticasone Propionate | 11 | $136 | $12 |
| Azithromycin | 11 | $83 | $8 |
2014: 2 drugs
| Spiriva | 20 | $6,577 | $329 |
| Advair Diskus | 15 | $5,715 | $381 |
2013: 2 drugs
| Spiriva | 13 | $3,545 | $273 |
| Symbicort | 12 | $2,594 | $216 |
Money from drug and device companies
$3,939 in 2023
| 2023 | 2 | 11 | None | $3,939 |
| 2022 | 2 | 4 | None | $182 |
| 2021 | 2 | 3 | None | $50 |
| 2020 | 1 | 2 | None | $52 |
| 2019 | 1 | 1 | None | $11 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Ion | $3,912 | 9 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $27 | 2 payments
|
See all 11 published payments
| Intuitive Surgical | Meals · 2023-10-24 | Da Vinci Surgical System | $95 |
| GlaxoSmithKline | Meals · 2023-05-23 | Trelegy Ellipta | $13 |
| Intuitive Surgical | Meals · 2023-04-27 | Da Vinci Surgical System | $16 |
| Intuitive Surgical | Education · 2023-04-27 | Ion | $3,000 |
| GlaxoSmithKline | Meals · 2023-03-21 | Trelegy Ellipta | $13 |
| Intuitive Surgical | Travel · 2023-03-14 | Da Vinci Surgical System | $77 |
| Intuitive Surgical | Meals · 2023-03-14 | Da Vinci Surgical System | $15 |
| Intuitive Surgical | Travel · 2023-03-14 | Da Vinci Surgical System | $151 |
| Intuitive Surgical | Travel · 2023-03-14 | Da Vinci Surgical System | $511 |
| Intuitive Surgical | Travel · 2023-03-14 | Da Vinci Surgical System | $36 |
| Intuitive Surgical | Meals · 2023-03-14 | Da Vinci Surgical System | $11 |
See earlier years (2022, 2021, 2020, 2019)
2022: $182
| Harmony Biosciences | Wakix | $140 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $42 | 2 payments
|
2021: $50
| GlaxoSmithKline | Anoro Ellipta | $31 | 2 payments
|
| Philips Electronics North America | (7999) Src Und | $19 | 1 payment
|
2020: $52
| GlaxoSmithKline | Anoro Ellipta | $52 | 2 payments
|
2019: $11
| GlaxoSmithKline | Trelegy Ellipta | $11 | 1 payment
|
Checkups this office reported
16 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 18%That's few of the people this applied to. | 582 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 39%That's less than half. | 278 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 4%That's few of the people this applied to. Better on this measure. | 48 |
| Breast cancer screeningEligible women who got a mammogram | 42%That's less than half. | 154 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 19%That's few of the people this applied to. | 177 |
| Checked for fall riskOlder patients screened for fall risk | 8%That's few of the people this applied to. | 373 |
| Colon cancer screeningEligible adults who got a colon cancer test | 21%That's few of the people this applied to. | 458 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 5%That's few of the people this applied to. | 851 |
See the other 8 measures
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 5%That's few of the people this applied to. | 40 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 75%That's most of the people this applied to. Worse on this measure. | 40 |
| HIV screeningEligible patients who were screened for HIV | 16%That's few of the people this applied to. | 640 |
| Medications listed in the chartVisits where the current medication list was documented | 72%That's more than half. | 2,073 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 390 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 328 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 82%That's most of the people this applied to. | 190 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 27%That's less than half. | 989 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
Professional record
- NPI
- 1295954121
- Licence
- CA 129323, NY 270208California A129323: Current · expires 2027-04-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RS0012X (207RS0012X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 1208 E Arques Ave Ste 113, Sunnyvale, CA, 94085
- NPI first listed
- 2007-04-25
- NPI last updated
- 2020-06-04
- NPI record certified
- 2020-06-04
This is when the NPI record was last certified, not a medical board exam.